The FDA accepted Takeda’s new drug application for TAK-721, its eosinophilic esophagitis treatment.
Dallas-based GI Alliance partnered with Gastrointestinal Associates in Jackson, Miss., expanding its presence into an eighth state.
GI Alliance expanded its Louisiana presence Dec. 17 through the acquisition of Metropolitan Gastroenterology Associates.
New York University Langone Health opened a new, comprehensive IBD center for adults with Crohn’s disease and ulcerative colitis.
More articles on surgery centers:
Ohio health system acquires surgery center for $21M
2 Texas health systems suspend surgeries, others don’t
Stryker’s ASC-focused business: 3 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
